NEW YORK, Aug. 10, 2017 -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Sequans Communications S.A. (“Sequans” or the “Company”) (NYSE:SQNS) of the October 10, 2017 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
If you invested in Sequans stock or options between April 29, 2016 and July 31, 2017 and would like to discuss your legal rights, click here: www.faruqilaw.com/SQNS. There is no cost or obligation to you.
You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected].
The lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of all those who purchased Sequans securities between April 29, 2016 and July 31, 2017 (the “Class Period”). The case, Renner v. Sequans Communications S.A. et al, No. 17-cv-04665 was filed on August 9, 2017, and has been assigned to Judge Frederic Block.
The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to appropriately recognize revenue misleadingly enhancing the Company’s financial results. Specifically, on August 1, 2017, Sequans revealed that its revenue in the second quarter of 2017 was negatively affected by a product return from an early 2016 tablet-product sale destined for Wal-Mart. After the announcement, Sequans’s share price fell from $3.68 per share on July 31, 2017 to a closing price of $2.87 on August 2, 2017—a $0.81 or a 22.01% drop.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Sequans’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
CONTACT: FARUQI & FARUQI, LLP 685 Third Avenue, 26th Floor New York, NY 10017 Attn: Richard Gonnello, Esq. [email protected] Telephone: (877) 247-4292 or (212) 983-9330


Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition 



